ALTERATIONS IN P53 AND P16(INK4) EXPRESSION AND TELOMERE LENGTH DURING SPONTANEOUS IMMORTALIZATION OF LI-FRAUMENI SYNDROME FIBROBLASTS

被引:0
|
作者
ROGAN, EM
BRYAN, TM
HUKKU, B
MACLEAN, K
CHANG, ACM
MOY, EL
ENGLEZOU, A
WARNEFORD, SG
DALLAPOZZA, L
REDDEL, RR
机构
[1] CHILDRENS MED RES INST,CANC RES GRP,SYDNEY,NSW 2145,AUSTRALIA
[2] ROYAL ALEXANDRA HOSP CHILDREN,CAMPERDOWN,NSW 2050,AUSTRALIA
[3] CHILDRENS HOSP MICHIGAN,CELL CULTURE LAB,DETROIT,MI 48201
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Normal cells have a strictly limited growth potential and senesce after a defined number of population doublings (PDs), In contrast, tumor cells often exhibit an apparently unlimited proliferative potential and are termed immortalized, Although spontaneous immortalization of normal human cells in vitro is an extremely rare event, we observed this in fibroblasts from an affected member of a Li-Fraumeni syndrome kindred, The fibroblasts were heterozygous for a p53 mutation and underwent senescence as expected at PD 40, In four separate senescent cultures (A to D), there were cells that eventually recommenced proliferation, This was associated with aneuploidy in all four cultures and either loss (cultures A, C, and D) or mutation (culture B) of the wild-type (wt) p53 allele. Loss of wt p53 function was insufficient for immortalization, since cultures A, B, and D subsequently entered crisis from which they did not escape. Culture C has continued proliferating beyond 400 PDs and thus appears to be immortalized, In contrast to the other cultures, the immortalized cells have no detectable p16(INK4) protein, A culture that had a limited extension of proliferative potential exhibited a progressive decrease in telomere length with increasing PD. In the culture that subsequently became immortalized, the same trend occurred until PD 73, after which there was a significant increase in the amount of telomeric DNA, despite the absence of telomerase activity, Immortalization of these cells thus appears to be associated with loss of wt p53 and p16(INK4) expression and a novel mechanism for the elongation of telomeres.
引用
收藏
页码:4745 / 4753
页数:9
相关论文
共 50 条
  • [31] Potential of Advexin®: a p53 gene-replacement therapy in Li-Fraumeni syndrome
    Nemunaitis, Jackie M.
    Nemunaitis, John
    FUTURE ONCOLOGY, 2008, 4 (06) : 759 - 768
  • [32] p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies
    Claudia Pötzsch
    Theda Voigtländer
    Michael Lübbert
    Journal of Cancer Research and Clinical Oncology, 2002, 128 : 456 - 460
  • [33] Germline p53 mutation in a case of Li-Fraumeni syndrome presenting gastric cancer
    Sugano, K
    Taniguchi, T
    Saeki, M
    Tsunematsu, Y
    Tomaru, U
    Shimoda, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (10) : 513 - 516
  • [34] COLLABORATIVE INTERDISCIPLINARY STUDIES OF P53 AND OTHER PREDISPOSING GENES IN LI-FRAUMENI SYNDROME
    LI, FP
    FRAUMENI, JF
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1994, 3 (08) : 715 - 717
  • [35] A novel dysfunctional germline P53 mutation identified in a family with Li-Fraumeni syndrome
    Ji, Min
    Wang, Lin
    Shao, Yuguo
    Cao, Wei
    Xu, Ting
    Chen, Shujie
    Wang, Zhiwei
    He, Qi
    Yang, Kuo
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (01): : 165 - 169
  • [36] p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies
    Pötzsch, C
    Voigtländer, T
    Lübbert, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (08) : 456 - 460
  • [37] Novel p53 splice site mutations in three families with Li-Fraumeni syndrome
    Verselis, SJ
    Rheinwald, JG
    Fraumeni, JF
    Li, FP
    ONCOGENE, 2000, 19 (37) : 4230 - 4235
  • [38] p53 codon 72 polymorphism and cancer risk in Li-Fraumeni syndrome.
    Yip, L
    Hwang, SJ
    Strong, LC
    Lozano, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 471 - 471
  • [39] GERM-LINE P53 MUTATIONS IN 15 FAMILIES WITH LI-FRAUMENI SYNDROME
    FREBOURG, T
    BARBIER, N
    YAN, YX
    GARBER, JE
    DREYFUS, M
    FRAUMENI, J
    LI, FP
    FRIEND, SH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 56 (03) : 608 - 615
  • [40] Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
    Olive, KP
    Tuveson, DA
    Ruhe, ZC
    Yin, B
    Willis, NA
    Bronson, RT
    Crowley, D
    Jacks, T
    CELL, 2004, 119 (06) : 847 - 860